FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

Allogeneic HCT has been increasingly used in the setting of FLT3 mutated AML. However, its role in conferring durable relapse-free intervals remains in question. Herein, we sought to investigate FLT3 mutational status on transplant outcomes. We conducted a retrospective cohort study of 262 consecuti...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Bone Marrow Transplant
Main Authors: Song, Yeohan, Magenau, John, Li, Yumeng, Braun, Thomas, Chang, Lawrence, Bixby, Dale, Hanauer, David A., Chughtai, Komal A., Gatza, Erin, Couriel, Daniel, Goldstein, Steven, Pawarode, Attaphol, Reddy, Pavan, Riwes, Mary, Connelly, James, Harris, Andrew, Kitko, Carrie, Levine, John, Yanik, Greg, Parkin, Brian, Choi, Sung Won
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720584/
https://ncbi.nlm.nih.gov/pubmed/26191952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.170
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker